Marsh & McLennan Companies, Inc. (MRSH)

NYQ · Financials · Insurance Brokers
By Alex · Tickerpine
$169.03
+6.80 (+4.19%)
Price — last 10 years monthly, dividend-adjusted · hover for detail
Market Cap
$81.44B
P/E (TTM)
21.1
Forward P/E
14.9
EPS (TTM)
$8.00
ROE
27.57%
Profit Margin
14.26%
Revenue Growth
7.60%
Dividend Yield
2.13%
Beta
0.61
52W High
$219.71
52W Low
$156.60
Analyst Target
$199.57
What would an investment in MRSH be worth today?
Run MRSH through our free historical return calculator.
Calculate MRSH returns →

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people worldwide. The company operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk management, insurance broking, insurance program management, risk consulting, analytical modeling, and alternative risk financing services. This segment also offers insurance and reinsurance broking, strategic advisory and actuarial services, and analytics solutions. It serves businesses, public entities, insurance companies, associations, professional services organizations, and private clients. The Consulting segment provides health, wealth and career advice, solutions and products; and specialized management, strategic, economic, and brand consulting services. Marsh & McLennan Companies, Inc. was founded in 1871 and is headquartered in New York, New York.

Company website ↗

MRSH Key Statistics

Previous Close$162.23P/E Ratio21.1
Market Cap$81.44BPEG Ratio1.63
Revenue (TTM)$27.52BROE27.57%
Gross Margin43.85%ROA7.27%
Debt / Equity151.6Employees95,000

MRSH in plain English

Compare MRSH with peers

MRSH vs BRK-BBerkshire Hathaway Inc. $498.66 MRSH vs JPMJPMorgan Chase & Co. $329.05 MRSH vs VVisa Inc. $336.23 MRSH vs MAMastercard Incorporated $499.02 MRSH vs BACBank of America Corporation $57.88

Data last refreshed from public sources. Figures may be delayed. Not investment advice.